MyFinsight
Home
Blog
About
Contact
Trade accounts
receivable
-$11,920K
Noncash interest
expense
$614K
Inventory write-down for
excess & obsolescence
$192K
Change in fair value of
financial instruments
-$162K
Amortization of intangible
asset
$75K
Loss on contingent
liability
$58K
Noncash right-of-use
asset amortization
$32K
Stock-based compensation
$15K
Depreciation
$4K
Net cash and cash
equivalents and net...
$2,301K
Canceled cashflow
$10,771K
Net change in cash
and cash...
$1,801K
Canceled cashflow
$500K
Net income (loss)
-$5,465K
Accrued expenses and
other liabilities
-$1,636K
Accounts payable
-$1,605K
Accrued compensation
-$1,092K
Inventories
$761K
Prepaid and other assets
$130K
Contingent liabilities
-$50K
Operating lease
liabilities
-$32K
Net cash and cash
equivalents and net...
-$498K
Net cash and cash
equivalents and net...
-$2K
Payments under short term
debt and notes ...
$498K
Purchases of property and
equipment
$2K
Back
Back
Cash Flow
Evofem Biosciences, Inc. (EVFM)
Evofem Biosciences, Inc. (EVFM)
source: myfinsight.com